Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer (Q41637922)
Jump to navigation
Jump to search
scientific article published on March 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer |
scientific article published on March 1, 1992 |
Statements
1 reference
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer (English)
A. D. Seidman
H. I. Scher
D. Petrylak
D. D. Dershaw
1 March 1992
1 reference
1 reference
147
1 reference
3 Pt 2
1 reference
931-934
1 reference
Identifiers
1 reference